Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 20,786 | 42,107 | 110,949 | 126,884 | 117,709 |
| Marketable Securities | N/A | N/A | N/A | 1,205 | 59,711 |
| Receivables | 44,350 | 42,744 | 37,211 | 72,482 | 102,589 |
| Inventories | 11,712 | 3,412 | 3,396 | 13,042 | 13,033 |
| TOTAL | $94,254 | $103,951 | $208,107 | $230,851 | $306,204 |
| Non-Current Assets | |||||
| PPE Net | 2,437 | 3,497 | 13,064 | 13,024 | 15,526 |
| Investments And Advances | 0 | 13,064 | 11,784 | 0 | 0 |
| Intangibles | 200,082 | 400,535 | 692,099 | 793,873 | 902,149 |
| Other Non-Current Assets | 6,501 | 6,123 | 7,812 | 869 | 1,458 |
| TOTAL | $209,020 | $423,219 | $724,759 | $807,766 | $919,133 |
| Total Assets | $303,274 | $527,170 | $932,866 | $1,038,617 | $1,225,337 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 11,942 | 80,000 | 120,000 | 82,500 | N/A |
| Accounts payable and accrued liabilities | 14,808 | 24,568 | 17,783 | 27,952 | 30,779 |
| Accrued Expenses | 91,978 | 77,891 | 107,120 | 196,324 | 190,934 |
| Other current liabilities | 13,958 | 2,094 | 1,133 | 3,678 | 5,470 |
| TOTAL | $132,686 | $184,553 | $246,036 | $310,580 | $227,242 |
| Non-Current Liabilities | |||||
| Long Term Debt | 72,160 | 271,258 | 158,309 | 274,720 | 466,051 |
| Other Non-Current Liabilities | 42,914 | 13,401 | 308,186 | 283,809 | 281,256 |
| TOTAL | $115,074 | $284,659 | $466,495 | $558,529 | $747,307 |
| Total Liabilities | $247,760 | $469,212 | $712,531 | $869,109 | $974,549 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,892 | 1,355 | 1,072 | 1,059 | 1,036 |
| Common Shares | 3 | 8 | 6 | 6 | 291,634 |
| Retained earnings | -427,945 | -399,801 | -182,600 | -219,508 | -116,744 |
| Other shareholders' equity | 0 | 0 | -5 | -5 | -19 |
| TOTAL | $55,514 | $57,958 | $220,335 | $169,508 | $250,788 |
| Total Liabilities And Equity | $303,274 | $527,170 | $932,866 | $1,038,617 | $1,225,337 |